Engano, Rovelyn T.

HRN: 17-83-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
CEFUROXIME 500MG (TAB)
06/29/2026
07/06/2026
PO
1 Tab
BID
SP NSD W RMLE
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines